Evidence map›Paper›PMID 27027682›Full record

ReviewCurrent opinion in nephrology and hypertension2016

Glomerular cell crosstalk.

Rachel Lennon, Salman Hosawi

Open access · hybridAbstract readReview
In one paragraph

Review in Current opinion in nephrology and hypertension, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Inflammation in glomerular diseases.Frontiers in immunology · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Recessive Mutations inKidney international reports · 2021
    Article
  8. Review
  9. Article
  10. A complex role for Bcl10 in kidney injury.Cardiovascular research · 2020
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. New Insights into Podocyte Biology in Glomerular Health and Disease.Journal of the American Society of Nephrology : JASN · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Rachel LennonaWellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences bInstitute of Human Development, Faculty of Human Sciences, University of Manchester cDepartment of Paediatric Nephrology, Central Manchester University Hospitals NHS Foundation Trust (CMFT), Manchester, UK dDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Salman Hosawi
Manchester University NHS Foundation Trust · GBWellcome Centre for Cell-Matrix Research · GB

Funding

Wellcome Trust 090006
6 · The paper itself

Abstract

purpose of reviewGlomerular filtration occurs in specialized, microscopic organelles. Each glomerulus contains unique cells and these cooperate to maintain normal filtration. Phenomenal adaptation is required for the glomerulus to respond to variable mechanical loads and this adaptation requires efficient communication between the resident cells. This review will focus on the latest discoveries related to signalling events that mediate the crosstalk between glomerular cells, and detail how disease processes can influence normal regulation. RECENT

findingsNew data indicate that the crosstalk between glomerular cells involves an increasing number of secreted signalling ligands that act in an autocrine or paracrine fashion. Furthermore, extended roles for some of the classical signalling molecules have been described and there is emerging evidence of therapeutic strategies to manipulate cellular crosstalk. The glomerular extracellular matrix harbours many of these signalling ligands, acting as a reservoir and presenting ligands to cell surface receptors. Signals can also be transferred between cells by extracellular vesicles and this is an emerging concept in cellular crosstalk. SUMMARY: Recent discoveries are building our understanding about glomerular cell crosstalk, and this review focuses on growth factors and signalling peptides, methods of delivery to target cells, and the potential for developing new therapies for glomerular disease.

Indexed as

AnimalsBasement MembraneCell CommunicationExtracellular MatrixHumansKidney DiseasesKidney GlomerulusSignal Transduction

Identifiers

PMID27027682
PMCPMC4825110
OpenAlexW2316734999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.